[1] Gonen-Gross T,Goldman-Wohl D,Huppertz B,et al. Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetal-maternal interface[J].PLoS One,2010,5(1):e8941. [2] Yan WH. Human leukocyte antigen-G in cancer: are they clinically relevant [J]. Cancer Letters,2011,311(2):123-130. [3] Zidi I, Ben Amor N. HLA-G regulators in cancer medicine: an outline of key requirements[J].Tumour Biol,2011,32(6):1071-1086. [4] Morandi F, Scaruffi P, Gallo F, et al. Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins[J].PLoS One,2012,7(1): e29922. [5] 何 维,高晓明,曹雪涛,等. 医学免疫学[M].北京:人民卫生出版社,2005:385. [6] Suciu-Foca N,Manavalan JS,Scotto L,et al. Mole-cular characterization of allospecific T suppressor and tolerogenic dendritic cells: review[J]. Int Immuno-pharmacol, 2005,5(1):7-11. [7] Rodríguez JA,Galeano L,Palacios DM,et al. Altered HLA class I and HLA-G expression is associated with IL-10 expression in patients with cervical cancer[J].Pathobiology, 2012,79(2):72-83. [8] Abediankenari S,Ghasemi M,Kim YJ. Human leukocyte antigen-G expression on dendritic cells induced by transforming growth factor-beta 1 and CD4+ T cells proliferation[J].Iran Biomed J,2011,15(1-2):1-5. [9] 黄庆梅,覃锦耀. CD4+CD25+细胞和CD8+CD28-调节性T细胞在原发性肝癌患者外周血中的水平变化[J]. 检验医学, 2010,25(9):705-707. [10] Elliott RL,Jiang XP,Phillips JT,et al. Human leukocyte antigen G expression in breast cancer: role in immunosuppression[J].Cancer Biother Radiopharm, 2011,26(2):153-157. |